US2014087358A1PendingUtilityA1

Methods and compositions for detecting rare cells from a biological sample

51
Assignee: AVIVA BIOSCIENCES CORPPriority: Jul 14, 2006Filed: Sep 17, 2013Published: Mar 27, 2014
Est. expiryJul 14, 2026(~0 yrs left)· nominal 20-yr term from priority
G01N 33/575G01N 33/5094Y10T436/25375C12N 5/0693G01N 2333/70525G01N 2015/1402G01N 33/56972G01N 2800/52G01N 2333/70589G01N 33/54346G01N 2015/1006
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides methods and compositions for isolating and detecting rare cells from a biological sample containing other types of cells. In particular, the present invention includes a debulking step that uses a microfabricated filters for filtering fluid samples and the enriched rare cells can be used in a downstream process such as identifies, characterizes or even grown in culture or used in other ways. The invention also include a method of determining the aggressiveness of the tumor or of the number or proportion of cancer cells in the enriched sample by detecting the presence or amount of telomerase activity or telomerase nucleic acid or telomerase expression after enrichment of rare cells. This invention further provides an efficient and rapid method to specifically remove red blood cells as well as white blood cells from a biological sample.

Claims

exact text as granted — not AI-modified
1 . A method of enriching target cells in a sample, which method comprises:
 a) Removing white blood cells (WBCs) from a biological sample by allowing them to bind to a specific binding member affixed to a solid support;   b) Removing red blood cells (RBCs) from the sample with a density-based method, to produce a sample enriched in the target cell type; and   c) Performing an analysis, manipulation or application step with the sample enriched in the target cell type to determine the number or presence of target cells.   
     
     
         2 - 37 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.